Published in Cardiovascular Device Liability Week, April 9th, 2006
The parties agreed that, subject to certain conditions, within 38 days of signing the agreement, King, Aventis and Cobalt will submit a joint stipulation dismissing without prejudice the litigation before the U.S. District Court for the District of Massachusetts.
Cobalt had sought to market generic versions of Altace...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.